Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Korro Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +9 vs. Q4 2023
- Shares held
- 6.91M
- +345.4K (+5.3%) vs. Q4 2023
- Total value
- $618.6M
- +$317.1M (+105.2%) vs. Q4 2023
- New holders
- 11
- 13 more added
- Sold out
- 2
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 106 | $190.1M |
| Q1 2026 | 99 | $144.8M |
| Q4 2025 | 83 | $60.6M |
| Q3 2025 | 92 | $465.5M |
| Q2 2025 | 71 | $114.8M |
| Q1 2025 | 75 | $169.0M |
| Q4 2024 | 84 | $359.6M |
| Q3 2024 | 71 | $285.3M |
| Q2 2024 | 64 | $285.7M |
| Q1 2024 | 49 | $618.6M |
| Q4 2023 | 40 | $301.5M |
| Q3 2023 | 42 | $2.58M |
| Q2 2023 | 41 | $1.67M |
| Q1 2023 | 43 | $2.52M |
| Q4 2022 | 50 | $28.3M |
| Q3 2022 | 55 | $14.1M |
| Q2 2022 | 58 | $13.0M |
| Q1 2022 | 86 | $33.1M |
| Q4 2021 | 84 | $90.2M |
| Q3 2021 | 88 | $130.4M |
| Q2 2021 | 91 | $193.9M |
| Q1 2021 | 115 | $186.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Korro Bio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 389 | $35 | 0.00% | +389 | New |
| Kelly Financial Services LLC | 1 | $90 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4 | $360 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 5 | $450 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 6 | $1.00K | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 20 | $1.80K | 0.00% | +20 | New |
| City State Bank | 20 | $2.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 29 | $2.35K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 49 | $4.41K | 0.00% | +1+2.1% | Added |
| Tower Research Capital LLC (TRC) | 50 | $4.50K | 0.00% | −3,912−98.7% | Reduced |
| Royal Bank of Canada | 97 | $9.00K | 0.00% | −821−89.4% | Reduced |
| UBS Group AG | 271 | $24.4K | 0.00% | −366−57.5% | Reduced |
| Quarry LP | 400 | $36.0K | 0.01% | +400 | New |
| Duncker Streett & Co Inc | 437 | $39.3K | 0.01% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 1,000 | $90.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 3,147 | $283.2K | 0.00% | +3,147 | New |
| Brevan Howard Capital Management LP | 3,602 | $324.2K | 0.03% | +3,602 | New |
| Balyasny Asset Management LLC | 3,773 | $339.6K | 0.00% | +3,773 | New |
| Bank of America Corp | 5,027 | $452.4K | 0.00% | +799+18.9% | Added |
| Morgan Stanley | 7,669 | $690.2K | 0.00% | +1,701+28.5% | Added |
| Renaissance Technologies LLC | 9,893 | $890.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 10,293 | $926.4K | 0.00% | −217−2.1% | Reduced |
| Susquehanna International Group, LLP | 11,276 | $1.01M | 0.00% | +11,276 | New |
| JPMorgan Chase & Co | 13,163 | $1.18M | 0.00% | +13,145+73,027.8% | Added |
| Marshall Wace, LLP | 13,407 | $1.21M | 0.00% | +13,407 | New |
| State Street Corp | 18,100 | $1.63M | 0.00% | +12,500+223.2% | Added |
| Citigroup Inc | 19,289 | $1.74M | 0.00% | +2,282+13.4% | Added |
| Qube Research & Technologies Ltd | 23,211 | $2.09M | 0.00% | +22,206+2,209.6% | Added |
| Jane Street Group, LLC | 25,814 | $2.32M | 0.00% | +18,449+250.5% | Added |
| ExodusPoint Capital Management, LP | 40,902 | $3.68M | 0.05% | +35,292+629.1% | Added |
| Goldman Sachs Group Inc | 45,171 | $4.07M | 0.00% | +45,171 | New |
| Monashee Investment Management LLC | 55,364 | $4.98M | 0.59% | −35,441−39.0% | Reduced |
| Geode Capital Management, LLC | 58,241 | $5.24M | 0.00% | +867+1.5% | Added |
| Millennium Management LLC | 60,894 | $5.48M | 0.00% | +60,894 | New |
| Invesco Ltd. | 72,419 | $6.52M | 0.00% | +72,419 | New |
| Suvretta Capital Management, LLC | 73,821 | $6.64M | 0.28% | 00.0% | Unchanged |
| BlackRock Inc. | 80,621 | $7.26M | 0.00% | −5,007−5.8% | Reduced |
| Verition Fund Management LLC | 140,091 | $12.6M | 0.12% | +82,005+141.2% | Added |
| Point72 Asset Management, L.P. | 265,826 | $23.9M | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 266,667 | $24.0M | 0.00% | −4,307−1.6% | Reduced |
| 72 Investment Holdings, LLC | 276,831 | $24.9M | 37.14% | 00.0% | Unchanged |
| Qiming U.S. Ventures Management, LLC | 368,085 | $33.1M | 36.93% | 00.0% | Unchanged |
| Artal Group S.A. | 419,226 | $37.7M | 0.97% | +621+0.1% | Added |
| Citadel Advisors LLC | 529,180 | $46.4M | 0.04% | +70.0% | Added |
| Cormorant Asset Management, LP | 529,170 | $47.6M | 2.10% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 537,490 | $48.4M | 0.76% | −8,835−1.6% | Reduced |
| FMR LLC | 727,205 | $63.4M | 0.00% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,072,936 | $96.6M | 5.99% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 1,119,292 | $100.7M | 9.30% | 00.0% | Unchanged |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4−100.0% | Sold out |